Atlas Trials

Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

Clinical trial NCT07526597 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07526597
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Start date
2026-09-01
Primary completion
2032-06-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.